Logo-ia
ImmunoAnalysis. 2022;2: 9 | Published on: 2022 Dec 26. doi: 10.34172/ia.2022.09

Original Research

Combinational Therapy of Acute Lymphoblastic Leukemia with Cyclophosphamide and BV6 Synergistically Induces Apoptosis in Leukemic Cells

Mohammad Sadeghi 1 ORCID, Hamid Hamdi Hajibaba 2, Yaser Valizadeh 3, Ali Akbar Movasaghpour Akbari 1, Abbas Ali Hosseinpour Feizi 1, Leili Aghebati-Maleki 2, Farhad Jadidi-Niaragh 2,4,5 * ORCID

Cited by CrossRef: 2

1- Khodakarami A, Kashani M, Nazer A, Kheshti A, Rashidi B, Karpisheh V, Masjedi A, Abolhasani S, Izadi S, Bagherifar R, Hejazian S, Mohammadi H, Movassaghpour A, Feizi A, Hojjat-Farsangi M, Jadidi-Niaragh F. Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide. Cell Commun Signal. 2023;21(1) [Crossref]
2- Rivera-Lazarín A, Calvillo-Rodríguez K, Izaguirre-Rodríguez M, Vázquez-Guillén J, Martínez-Torres A, Rodríguez-Padilla C. Synergistic Enhancement of Chemotherapy-Induced Cell Death and Antitumor Efficacy against Tumoral T-Cell Lymphoblasts by IMMUNEPOTENT CRP. IJMS. 2024;25(14):7938 [Crossref]